OncoVista Innovative Therapies, Inc. (OTCBB:OVIT) reported that it has initiated an additional safety study of OVI-117 in a 2nd animal species. “OncoVista is moving ahead...
OncoVista Innovative Therapies, Inc., (OTCBB:OVIT) reported in a letter to shareholders that it is moving forward on its business plan to develop targeted, safer and more...
OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biopharmaceutical company commercializing diagnostic tests for metastatic tumors, as well as developing...
AdnaGen AG, a subsidiary of OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biotech company developing proprietary, leading-edge early detection and...
OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biotech company developing proprietary, leading-edge early detection and drug technologies to enable...
OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biotech company developing proprietary, leading-edge early detection and drug technologies to enable...
OncoVista Innovative Therapies, Inc. (OTCBB:OVIT) announced today that its wholly owned subsidiary, AdnaGen AG, the manufacturer of CE-certified circulating tumor cell (CTC...
OncoVista Innovative Therapies, Inc. (OTCBB: OVIT) announced today that its application for reinstatement on the Over-The-Counter Bulletin Board has been accepted...
OncoVista Innovative Therapies, Inc. (Pink Sheets:OVIT), reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now...
OncoVista Innovative Therapies, Inc. (Pink Sheets: OVIT) reported continued strong growth in revenue, in the third quarter of 2009. For the nine months ended, revenues increased...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0.0002 | 0.0002 | 0.0001 | 30445 | 0.00018905 | CS |
26 | 0.000199 | 19900 | 1.0E-6 | 0.0002 | 1.0E-6 | 16534 | 0.0001494 | CS |
52 | 0.0001 | 100 | 0.0001 | 0.0002 | 1.0E-6 | 29665 | 0.00011258 | CS |
156 | 0.000199 | 19900 | 1.0E-6 | 0.0002 | 1.0E-6 | 24039 | 0.00014618 | CS |
260 | -0.0198 | -99 | 0.02 | 0.137 | 1.0E-6 | 38492 | 0.03710013 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約